Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Dr. Martin …
Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Dr. Martin …
Orchard Therapeutics has secured reimbursement from another European market for Libmeldy, an ex vivo gene therapy for the rare childhood …
Listen to the article 8 min This audio is auto-generated. Please let us know if you have feedback. Just as …
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. The cardiovascular …
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Welcome to …
Less than a week into the tenure of Robert F Kennedy Jr as Health and Human Services (HHS) Secretary, there …
The week has ended with a flurry of M&A in the drug industry, with Cosette Pharmaceuticals agreeing to buy Australia’s …
A proposed merger of the UK’s Poolbeg Pharma with Austrian biotech Hookipa has been called off after the latter abruptly …
Sales of Amgen’s Blincyto have grown slowly since it was first introduced a decade ago, but have started to gather …
An inhaled gene therapy for cystic fibrosis developed by Boehringer Ingelheim is due to start clinical testing shortly, hoping to …
Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:
Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC